Inventor · disambiguated record
Eric A. Kitas
Also filed as: KITAS ERIC · KITAS ERIC A · KITAS ERIC ARGIRIOS
32 granted patents·7 pending applications·381 citations·filing 2001–2023
96Inventor score
Files withHOFFMANN LA ROCHE20TARGIMMUNE THERAPEUTICS AG5ROZEMA DAVID B4UNIV INDIANA RES & TECH CORP3ARROWHEAD MADISON INC2
Top patents by PatentIndex Score
39 records- 0198US8501930B2Peptide-based in vivo siRNA delivery systemROZEMA DAVID B·Filed 2011·Granted Aug 6, 2013·180 cites·18 claims
- 0295US9796756B2Galactose cluster-pharmacokinetic modulator targeting moiety for siRNAARROWHEAD MADISON INC·Filed 2015·Granted Oct 24, 2017·24 cites·20 claims
- 0395US8802773B2In vivo polynucleotide delivery conjugates having enzyme sensitive linkagesROZEMA DAVID B·Filed 2013·Granted Aug 12, 2014·12 cites·22 claims
- 0495US8426554B2In vivo polynucleotide delivery conjugates having enzyme sensitive linkagesROZEMA DAVID B·Filed 2011·Granted Apr 23, 2013·47 cites·14 claims
- 0586US9011919B2Compositions for targeted delivery of siRNAROZEMA DAVID B·Filed 2012·Granted Apr 21, 2015·7 cites·22 claims
- 0685US7160875B2Malonamide derivativesHOFFMANN LA RACHE INC·Filed 2004·Granted Jan 9, 2007·31 cites·24 claims
- 0784US10428108B2Difluoroketamide derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Oct 1, 2019·5 cites·24 claims
- 0884US9249179B2Galactose cluster-pharmacokinetic modulator targeting moiety for siRNAHADWIGER PHILIPP·Filed 2011·Granted Feb 2, 2016·10 cites·5 claims
- 0983US9301990B2Small molecule conjugates for intracellular delivery of biologically active compoundsHOFFMANN LA ROCHE·Filed 2013·Granted Apr 5, 2016·2 cites·6 claims
- 1083US9107957B2Peptide-based in vivo siRNA delivery systemARROWHEAD MADISON INC·Filed 2013·Granted Aug 18, 2015·5 cites·14 claims
- 1182US9868772B2Analogs of glucagon exhibiting GIP receptor activityUNIV INDIANA RES & TECH CORP·Filed 2013·Granted Jan 16, 2018·4 cites·3 claims
- 1280US9968647B2Small molecule conjugates for intracellular delivery of biologically active compoundsHOFFMANN LA ROCHE·Filed 2016·Granted May 15, 2018·1 cites·3 claims
- 1380US7253158B2SulfonamidesHOFFMANN LA ROCHE·Filed 2005·Granted Aug 7, 2007·4 cites·12 claims
- 1480US6790860B2Pyrrolidine derivativesHOFFMANN LA ROCHE·Filed 2003·Granted Sep 14, 2004·10 cites·23 claims
- 1578US9198947B2Small molecule conjugates for intracellular delivery of nucleic acidsHOFFMANN LA ROCHE·Filed 2013·Granted Dec 1, 2015·1 cites·5 claims
- 1678US7375099B2Malonamide derivativesHOFFMANN LA ROCHE·Filed 2004·Granted May 20, 2008·13 cites·19 claims
- 1776US10208087B2PeptidesHOFFMANN LA ROCHE·Filed 2015·Granted Feb 19, 2019·2 cites·6 claims
- 1876US7166587B2Carbamic acid alkyl ester derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Jan 23, 2007·9 cites·27 claims
- 1970US7189756B2Pyrrolidine derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Mar 13, 2007·3 cites·59 claims
- 2070US6541638B2Pyrrolidine derivativesHOFFMANN LA ROCHE·Filed 2001·Granted Apr 1, 2003·5 cites·15 claims
- 2167US2024033364A1Castration resistant prostate cancerTARGIMMUNE THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 2264US7173109B2Fluorescently labeled growth hormone secretagogueHOFFMANN LA ROCHE·Filed 2004·Granted Feb 6, 2007·5 cites·7 claims
- 2363US6444829B1Pyrrolidine compoundsHOFFMANN LA ROCHE·Filed 2001·Granted Sep 3, 2002·1 cites·42 claims
- 2461US11679160B2Castration resistant prostate cancerTARGIMMUNE THERAPEUTICS AG·Filed 2018·Granted Jun 20, 2023·0 cites·20 claims
- 2554US2025135014A1Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the sameTARGIMMUNE THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 2652US7186798B2Fluorescently labeled growth hormone secretagogueHOFFMANN LA ROCHE·Filed 2005·Granted Mar 6, 2007·0 cites·5 claims
- 2751US10137170B2Lipidated incretin receptor ligand human immunoglobulin Fc-region fusion polypeptidesUNIV INDIANA RES & TECH CORP·Filed 2014·Granted Nov 27, 2018·0 cites·3 claims
- 2850US2018105569A1Analogs of glucagon exhibiting gip receptor activityUNIV INDIANA RES & TECH CORP·Filed 2017·Application pending·0 cites
- 2949US7973051B2Aminothiazoles as FBPase inhibitors for diabetesHOFFMANN LA ROCHE·Filed 2008·Granted Jul 5, 2011·0 cites·6 claims
- 3049US2002040146A1Pyrrolidine derivativesFiled 2001·Application pending·0 cites
- 3148US2023372384A1Immunotherapy for the treatment of cancerTARGIMMUNE THERAPEUTICS AG·Filed 2021·Application pending·0 cites
- 3247US7501406B2Fluoro substituted 2-oxo-azepan derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Mar 10, 2009·0 cites·13 claims
- 3346US7964633B2Sulfonamide derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Jun 21, 2011·0 cites·20 claims
- 3446US2022175814A1Immunotherapy for the treatment of cancerTARGIMMUNE THERAPEUTICS AG·Filed 2020·Application pending·0 cites
- 3545US8163778B2Pyridines as FBPase inhibitors for treatment of diabetesHAAP WOLFGANG·Filed 2008·Granted Apr 24, 2012·0 cites·7 claims
- 3644US10683329B2Dual-site BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2015·Granted Jun 16, 2020·0 cites·15 claims
- 3744US7868030B2FBPase inhibitors for diabetesHOFFMANN LA ROCHE·Filed 2007·Granted Jan 11, 2011·0 cites·19 claims
- 3841US10947272B2BACE1 inhibitor peptidesHOFFMANN LA ROCHE·Filed 2016·Granted Mar 16, 2021·0 cites·11 claims
- 3937US2003125257A1Assay for identifying beta secretase inhibitorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eric A. Kitas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →